Circulating tumor cells as a “real-time liquid biopsy”: Recent advances and the application in ovarian cancer

Hei Jen Jou*, Pei Ying Ling, Heng Tung Hsu

*此作品的通信作者

研究成果: Review article同行評審

8 引文 斯高帕斯(Scopus)

摘要

Even with the latest advances in technology, the treatment of ovarian cancer remains a big challenge because it is typically diagnosed at advanced stage, is prone to early relapse in spite of aggressive treatment and has an extremely poor prognosis. Circulating tumor cells (CTCs) can be used as a non-invasive “real-time liquid biopsy”, which has shown the value of diagnosis, assessment of prognosis and chemoresistance, and detection of small residual tumors on ovarian cancer. This review article provides an overview on recent research on CTCs in ovarian cancer, with special focus on the clinical application of CTC tests.

原文English
期刊Taiwanese Journal of Obstetrics and Gynecology
DOIs
出版狀態Accepted/In press - 2021

指紋

深入研究「Circulating tumor cells as a “real-time liquid biopsy”: Recent advances and the application in ovarian cancer」主題。共同形成了獨特的指紋。

引用此